Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Angiogenesis, the process of forming new blood vessels, is a fundamental biological phenomenon critical for growth and repair. However, aberrant angiogenesis is a hallmark of several debilitating diseases, including cancer, where it fuels tumor growth and metastasis, and age-related macular degeneration (AMD), which involves abnormal blood vessel development in the eye. Identifying compounds that can effectively modulate this process is a major focus in medical research. Ammonium Tetrathiomolybdate (ATM), available from NINGBO INNO PHARMCHEM CO.,LTD., is emerging as a significant agent in this area, offering promising therapeutic potential. As a leading manufacturer and supplier, we are at the forefront of providing this critical research chemical.
Understanding Angiogenesis and its Aberrations:
New blood vessel formation is tightly regulated by a balance of pro-angiogenic and anti-angiogenic factors. In pathological conditions, this balance is tipped, leading to excessive or inappropriate vascularization. For instance, tumors require a robust blood supply to thrive, making angiogenesis inhibitors a key strategy in cancer therapy. Similarly, in wet AMD, abnormal blood vessels leak fluid and blood, damaging vision.
Ammonium Tetrathiomolybdate's Role in Inhibition:
Research indicates that Ammonium Tetrathiomolybdate (CAS 15060-55-6) possesses potent anti-angiogenic properties. While the exact mechanisms are still under investigation, it is believed to interfere with copper-dependent enzymes and signaling pathways essential for endothelial cell function and blood vessel formation. This makes ATM a subject of intense interest for drug development. Scientists and pharmaceutical companies frequently inquire about the price of ATM to facilitate their research and development efforts.
Therapeutic Potential and Sourcing Reliability:
The investigation of ATM for conditions like cancer and AMD represents a significant advancement in targeted therapy. Its ability to inhibit angiogenesis offers a novel approach to disease management. For researchers and drug developers, securing a consistent supply of high-purity ATM is essential. NINGBO INNO PHARMCHEM CO.,LTD., as a trusted ammonium tetrathiomolybdate manufacturer in China, ensures the quality and availability of this vital compound. We cater to the needs of the global scientific community, providing reliable access to chemicals that drive innovation.
If your research or development involves angiogenesis inhibition, or if you are seeking a dependable source for Ammonium Tetrathiomolybdate, we encourage you to contact NINGBO INNO PHARMCHEM CO.,LTD. We are committed to supporting your work with premium chemical products and expert service. Purchase ATM from a leading global supplier and advance your groundbreaking research.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
